Synopsis: Astral Chemie Limited, a subsidiary of Astral Limited, has acquired a 60% stake in Differentiated and Sustainable Solutions LLP (DSS) for ₹ 39.11 crore. Astral’s adhesives company’s backward integration push opens up direct opportunities in high-value B2B tech sectors like aerospace, electronics, and green energy.
As per the National Stock Exchange (NSE), the current market price of Astral Limited is Rs. 1,504.20 per share (as on June 12, 2026). The stock touched a low of ₹1,498.50 and a high of ₹1,531.30 in the intra-day trading session. At this price level, the firm has a market value of ₹40,394 crore.
Earnings per share (EPS) for the trailing twelve-month period are Rs 19.97 for Astral. This means that the company’s price-to-earnings ratio is 73.3 times. Astral, with a P/E of 32.21x for the broader industry, is trading at a large premium, which shows the market expects high growth for its increasing chemical and building materials portfolio.
The Deal
Astral Limited stated that its wholly owned subsidiary, Astral Chemie Limited (previously Astral Coatings Private Limited), has entered into definitive agreements to buy a 60% partnership interest in Differentiated and Sustainable Solutions LLP (DSS). The consideration for the deal amounts to Rs. 39.11 crore.
The transaction is expected to close on or before August 31, 2026, subject to customary closing conditions. Upon completion, DSS will be a direct subsidiary of Astral Chemie and a step-down subsidiary of the listed parent, Astral Limited.
How the money works
The purchase is structured economically as an all-cash deal, where Astral uses its current cash of ₹39.11 crore to buy a controlling stake. Astral’s acquisition of a 60% share in the entire DSS operation is being valued at around ₹65.18 crore. DSS has a dedicated manufacturing facility in an industrial estate of Vilayat GIDC in Bharuch, Gujarat, with the existing capacity of 5,200 MTPA.
Financials
- FY 2024 Revenue: ₹1.44 crore
- Turnover in FY 2025: ₹6.41 crore
- FY 2026 Turnover (Unaudited): ₹3.21 crore
Upon closing the transaction, Astral will completely integrate 100% of DSS’s top-line and operating profits into its consolidated financial statements, adjusted for the 40% non-controlling interest.
Why does this fit the company?
This deal is less about grabbing immediate revenue and more about getting hold of rare tech and independence from raw material. India is today significantly dependent on imports from outside for sophisticated speciality products like polyamines, bismaleimides and benzoxazines. DSS is the only domestic player in India with proprietary technology to manufacture these specific chemical categories.
This is a big strategic benefit to Astral
Securing the Supply Chain Backward Integration)These speciality chemicals are key building blocks and curing agents to make epoxies, polyurethanes and industrial adhesives – the very product lines that Astral provides through its adhesives and construction chemicals vertical.
Getting into future tech fields, This is Astral’s entrance point into high-margin, high-barrier B2B industrial value chains like aerospace, defence, electronics and renewable energy systems.
What do accounts reveal?
- Astral has a healthy current ratio of 1.85x, indicating that its short-term liquid assets exceed its short-term liabilities, ensuring sufficient liquidity for daily operations.
- The company’s debt-to-equity ratio is 0.05x, which is conservative. It has almost no debt, so its expansion plans are backed by internal profits, not risky borrowing.
- The management allocates capital efficiently with a 17.5% ROE and 22% ROCE.
- Cash flow from operations consistently exceeds ₹500 crore annually. Spending ₹39.11 crore on this deal does not require new debt or strain the balance sheet.
The technical part is strong, but individual investors need to keep an eye on two important factors moving forward
- DSS’s revenues dropped from ₹6.41 crore in FY25 to ₹3.21 crore in FY26. This indicates that the company relies significantly on inconsistent B2B orders or lengthy qualification processes for institutional clients.
- The factory can handle up to 5,200 metric tonnes. Investors should monitor how quickly Astral can increase production, adjust internal raw material prices, and enter international markets such as the US, EU, and Japan, where demand for these products is strong.
The takeaway
Corporate finance-wise, this transaction has unequal risk and return. Astral is spending Rs 39.11 crore, a minor shift in its Rs 40,000+ crore market capitalisation, to buy highly guarded, import-substituting chemical formulations.
Sales fluctuations over the years make DSS’s cash flows small and uncertain. Making key adhesive components instead of buying them nearly guarantees structural cost savings over time. If tech transfers work, Astral’s chemical section has a strong competitive moat. If it encounters friction, the capital at risk is too little to affect the parent firm’s value.
Astral Limited (Astral) is a prominent construction materials and infrastructure solutions company in India. Founded in 1996, The firm pioneered India’s introduction of Chlorinated Polyvinyl Chloride (CPVC) pipe systems and has grown to be a highly diversified industrial conglomerate
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.are their own and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
